Advancing ALS Research with DHTs: Where Are We Now?
ActiGraph
MAY 6, 2024
This isn’t because there isn’t a drug pipeline; over 110 Phase 2 and Phase 3 industry-sponsored trials were started over the last decade (2013 – 2023 on clinicaltrials.gov). Sadly, this trend continued with two recent failed clinical trials, including the Phase 3 trial for Relyvrio and the Phase 2 trial for SAR443820/DNL788.
Let's personalize your content